Landmark clinical trial redefines multidrug-resistant TB treatment options

endTB clinical trial offers multiple new shortened drug regimens to treat adults and children with multidrug–resistant TB.

Read More →

New TB drugs are safe, effective alternatives

New interim findings from endTB indicate bedaquiline and delamanid could benefit many more patients.

Read More →

Webinar about the endTB trial: evaluating newly approved drugs for multidrug-resistant TB

9 June 2016
9-10 am EDT (15:00-16:00 CET)

Read More →

Page 1 of 1 · Total posts: 3